Chronic Liver Disease - MNEMONICS
DEFINITION :
A DISEASE PROCESS OF LIVER PARENCHYMA
Involves A Process Of PROGRESSIVE DESTRUCTION Leading To An Architectural Distortion With The Formation Of REGENERATIVE NODULES
Results In A NET DECREASE In HEPATOCELLULAR MASS, FUNCTION And An ALTERATION OF BLOOD FLOW
FINAL COMMON PATHWAY Of Many Types Of Chronic Liver Injury - LIVER CIRRHOSIS
EPIDEMIOLOGY :
400,000 Cases - Prevalence In U.S
Alcoholic Cirrhosis :
MOST COMMON TYPE (NORTH AMERICA, WESTERN EUROPE, SOUTH AMERICA)
Only 10 - 15 % Of Individuals With Excessive Alcohol Intake Develop Cirrhosis
Hepatitis C :
5,000,000 People (EXPOSED To HEPATITIS C VIRUS) - In U.S
RULE OF THUMBS :
80 % - Will Develop CHRONIC HEPATITIS C
20 - 30 % Of Those 80 % - Will Develop CIRRHOSIS Over 20 - 30 Years
Hepatitis B :
OVER 300 - 400 Million People (WORLDWIDE)
Endemic - Southeast Asia, Sub-Saharan Africa
1,250,000 People (CARRIERS Of HEPATITIS B) - In U.S
RULE OF THUMBS :
5 % - Will Develop CHRONIC HEPATITIS B
20 % Of Those 5 % - Will Develop CIRRHOSIS
Primary Biliary Cirrhosis (PBC) :
100 - 200 People / 1,000,000 Population - PREVALENCE
FEMALE > MALE
AGE Median - 50 Years Old
Cryptogenic Cirrhosis :
Up To 10 % Of All Patients With Cirrhosis (UNKNOWN Etiology)
ETIOLOGY :
Viral (POST HEPATITIC CIRRHOSIS) :
Hepatitis B Virus, Hepatitis C Virus, Cytomegalovirus (CMV), Epstein Barr Virus (EBV)
Toxin And Drugs :
Alcohol (ALCOHOLIC CIRRHOSIS), Amiodarone, Methotrexate, Nitrofurantoin
Metabolic :
Non-Alcoholic Fatty Liver Disease, Haemochromatosis, Wilson's Disease
Autoimmune :
Autoimmune Chronic Hepatitis, Primary Biliary Cirrhosis, Primary Sclerosing Cholangitis
Others :
Right Sided Congestive Heart Failure (CARDIAC CIRRHOSIS), Unknown (CRYPTOGENIC CIRRHOSIS)
MNEMONICS :
ABCDEFG
A - Alfa 1 Antitrypsin Deficiency
B - Budd Chiary Syndrome, Hepatitis B Virus, Billiary Cirrhosis, Bilharzia
C - Hepatitis C Virus, Cystic Fibrosis, Copper Overload
D - Drugs
Amiodarone, Methotrexate, Nitrofurantoin
E - Ethanol (Alcoholic Liver Diseae)
F - Fe Overload
Hemochromatosis, Hemosiderosis
G - Glycogen Storage Disease
TYPE OF CIRRHOSIS :
Type Of Cirrhosis (Classification)
DIAGNOSIS :
CLINICAL MANIFESTATION :
Asymptomatic - SOME
Non-Specific Symptoms :
Anorexia, Weight Loss, Fatigue / Weakness, Reduction In Skeletal Muscle Mass / Muscle Wasting
Skin And Hair :
Progressive Jaundice, Spider Angiomas, Palmar Erythema, Pruritus, Xanthelasmas, Xanthoma, Decrease Body Hair, Melanosis (Primary Biliary Cirrhosis)
Abdomen :
Firm, Nodular Liver, Splenomegaly, Ascites
Endocrine :
Gynecomastia, Testicular Atrophy, Menstrual Irregularities, Signs Of Virilization In Women
Hematologic / Vascular :
Caput Medusa, Easy Bruising And Bleeding, Hematemesis / Bleeding From Gastroesophageal Varices, Melena
Other :
Encephalopathy, Parotid And Lacrimal Gland Enlargement, Digital Clubbing, Melanosis, Steatorrhea, Edema
MNEMONICS :
ABCDEFGHIJ
LABORATORY :
Complete Blood Count
Anemia (Microcytic - Due To Blood Loss, Or Macrocytic - Due To Folate Deficiency)
Pancytopenia - Due To Hypersplenism
Serum Transaminases - ELEVATED
Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT)
Alcoholic Liver Disease - AST / ALT = 2 : 1
Serum Bilirubin
Prothrombin Time (PT) - PROLONGED
Serum Albumin - HYPOALBUMINEMIA
Serum Electrolyte - HYPONATREMIA, HYPOKALEMIA (Hypokalemic Alkalosis
Fe OVERLOAD
Serum Iron, Total Iron-Binding Capacity (TIBC), Serum Ferrition
Autoimmune Hepatitis
Antinuclear Antibody, Anti-Smooth-Muscle Antibody
Antimitochondrial Antibody (AMA) - PRIMARY BILIARY CIRRHOSIS
Present In Around 90% Of Patients With Primary Biliary Cirrhosis
Present In < 5 % Of Patients With Other Liver Diseases
Antineutrophil Cytoplasmic Antibody (P-ANCA) - PRIMARY SCLEROSING CHOLANGITIS
Positive In About 65% Of Patients With Primary Sclerosing Cholangitis
Gamma-Glutamyl Transpeptidase And Alkaline Phosphatase - ELEVATED
Hepatitis Serologies
HBsAg, Anti-HBs, Anti-HBc, HBeAg, Anti-HBe, HBV-DNA,
Anti-HCV, HCV-RNA, HCV Genotype
Anti-HDV
Alpha-1 Antitrypsin Level
IMAGING :
Abdominal Ultrasounds With Doppler, CT Scan, Or MRI
Cirrhotic Liver, Splenomegaly, Development Of Collateral Vessels
Venous Thrombosis
Magnetic Resonance Cholangiopancreatography (MRCP)
Imaging Technique Of Choice For Initial Evaluation Of Primary Sclerosing Cholangitis
Multifocal Stricturing And Beading Involving Both The Intrahepatic And Extrahepatic Biliary Tree
PROCEDURES :
Liver Biopsy
Percutaneous, Transjugular, Or Open Biopsy
DEFINITIVE DIAGNOSIS
MANAGEMENT :
NON-SPECIFIC :
Alcoholic Liver Disease
Abstinence Of Alcohol Intake (CORNERSTONE Of Therapy)
Nutrition And Long Term Medical Surpervision
Posthepatitic Liver Disease
Antiviral Therapy - For Chronic Hepatitis B And Chronic Hepatitis C Infection
Immunosuppresive Therapy - For Autoimmune Hepatitis
Primary Biliary Cirrhosis (PBC)
No Specific Therapy
URSODIOL - Has Been Shown To Improve Biochemical And Histologic Features
CHOLESTYRAMINE - May Reduce Pruritus And Hypercholesterolemia
Cardiac Cirrhosis
Treat The UNDERLYING CARDIAC DIORDER
SPECIFIC :
Alcoholic Liver Disease (Alcoholic Cirrhosis)
Directed To Prevent And To Managed Particular Complications
OTHERS :
Acamprosate (REDUCE Craving For Alcohol), S-Adenosyl Methionine, Anabolic Glucocorticoids (Propylthiouracil, Antioxidants, Colchisine, And Penicillamine), Oral Pentoxifylline, TNF Alpha (Infliximab Or Etanercept),
Posthepatitic Cirrhosis
Directed To Prevent And To Managed Particular Complications
Hepatitis B - Antiviral Therapy
Lamivudine, Adefovir, Entecavir, Tenofovir
Interferon Alpha
Can Also Be Used For Treating Hepatitis B, But Should Not Be Used In Cirrhotics
Hepatitis C - PEG-Interferon, And Ribavirin
Autoimmune Hepatitis (AIH) - Immunosuppressive Therapy
LIVER TRANSPLANTATION - An OPTION For Selected Patients
Primary Biliary Cirrhosis (PBC)
Pruritus - Antihistamine, Narcotic Receptor Antagonists (Naloxone Or Naltrexone), Rifampin, Cholestyramine, Plasmapheresis
Fatigue - Frequent Rest
Osteoporosis - Biphosphonate
Ursodiol - Indicated In Patients With Positive Antimitochondrial Antibodies And Elevated Biochemical Markers
Primary Sclerosing Cirrhosis (PSC)
NO SPECIFIC PROVEN TREATMENT
LIVER TRANSPLANTATION - Ultimate Treatment
Variceal Bleeding
Acute Hemorrhage
Supportive And Resuscitative Management (ICU Monitoring)
Fluid Resuscitation (Intravenous Fluid And Blood Product Replacement)
Vasoconstrictors
Somatostatin Or Octreotide - DIRECT SPLANCHNIC VASOCONSTRICTORS
Somatostatin 250 mcg Bolus Followed By 250 mcg / Hour
Octreotide 50 - 100 mcg / Hour
Vasopressin - NO LONGER COMMONLY USED
Balloon Tamponade
In Patients Who Cannot Get Endoscopic Therapy Immediately Or Who Need Stabilization Prior To Endoscopic Therapy
Endoscopic Intervention
FIRST LINE Of TREATMENT
Variceal Band Ligation
Used To Control Acute Bleeding In Over 90% Of Cases
Should Be Repeated Until Obliteration Of All Varices Is Accomplished
Sclerotherapy (Variceal Injection Therapy)
Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Reserved For Those Who Fail Endoscopic Or Medical Management
As A Bridge To LIVER TRANSPLANTATION
Encephalopathy Can Occur In As Many As 20% Of Patients After TIPS
Surgical Esophageal Transsection
Rarely Used And Associated With Poor Outcome
Prevention Of Recurrent Bleeding
Repeated Variceal Band Ligation - Until Varices Are OBLITERATED
Beta Blockade
Portosystemic Shunt Surgery
Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Liver Transplantation
Splenomegaly
Requires NO SPECIFIC TREATMENT - Usually
Splenectomy
SHOULD BE AVOIDED In Patients Eligible For LIVER TRANSPLANTATION
Ascites
Minimum Amounts Of Ascites
Dietary Sodium Restriction ( < 2 Grams Of Sodium Per Day )
Moderate Amounts Of Ascites
Spironolactone 100 - 200 mg / day (MAX : 400 mg / day)
Furosemide 40 mg / day (MAX : 160 mg / day )
Refractory Ascites
Repeated LARGE VOLUME PARACENTESIS
Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Spontaneous Bacterial Peritonitis (SBP)
INITIALLY :
Empirical Therapy (Gram Negative Aerobic Bacilli And Gram Positive Cocci)
Third Generation Cephalosporins
Cefotaxime 2 Grams Q 8 Hours Intravenous
Broad Spectrum Antibiotics
Piperacillin / Tazobactam 3.375 Grams Q 6 Hours Intravenous
Ceftriaxone 2 Grams Q 24 Hours Intravenous
After Organism Is Identified - Treatment Should Target The SPECIFIC PATHOGEN
Duration :
5 Days - If With Negative Blood Cultures, And With Rapid Improvement
Up To 2 Weeks - If With Positive Blood Cultures, And With Slow Improvement
PROPHYLAXIS
Given For Patients Who Have Had An Episode Of Spontaneous Bacterial Peritonitis And Recovered
Once-Weekly Administration Of Antibiotics For Recurrent SBP
Hepatorenal Syndrome (HRS)
DIFFICULT And UNSUCCESSFUL
Midodrine With Octreotide And Intravenous Albumin
Hepatic Encephalopathy
Hydration And Correction Of Electrolyte Imbalance
Lactulose - 30 To 120 mL Once Daily (OD) Up To 4X A Day (QID)
Target : 2 - 3 Bowel Movements / Day
Antibiotics - ADJUNCTIVE Therapy
Neomysin 500 - 1000 mg QID
Metronidazole 250 mg TID
Others : RIFAMIXIN
Zinc Supplementation
Coagulopathy
Asymptomatic - OBSERVE
Vitamin K - Intravenous Or Intramuscular
Bleeding :
Platelet Transfusion - If With Thrombocytopenia
Fresh Frozen Plasma - If With Prolonged Prothrombin Time
Others :
Replacement Of Factor VII - Can Correct Factor VII
Hepatopulmonary Syndrome (HPS)
No Specific Treatment
Embolization Of Large Arteriovenous Shunts
LIVER TRANSPLANTATION - In Selected Patients
COMPLICATIONS :
Portal Hypertension
Clinically Significant Portal Hypertension Is Present In > 60% Of Patients With LIVER CIRRHOSIS
Further Complications :
Gastroesophageal Varices (With Hemorrhage), Ascites, Splenomegaly
Spontaneous Bacterial Peritonitis (SBP) - POOR PROGNOSIS
Hepatorenal Syndrome (HRS)
Worsening AZOTEMIA With Avid Sodium Retention And Oliguria In The ABSENCE OF IDENTIFIABLE SPECIFIC CAUSES OF RENAL DYSFUNCTION
Hepatic Encephalopathy
Disturbances In Consciousness And Behavior, Personality Changes, Fuctuating Neurologic Signs, Asterixis, Distinctive EEG Changes
Coagulopathy
Thrombocytopenia, And Prolongation Of Prothrombin Time (PT)
Hypoxemia And Hepatopulmonary Syndrome (HPS)
Hepatocellular Carcinoma
Cholangiocarcinoma In Primary Sclerosing Cholangitis (PSC)
Malnutrition
Due To POOR DIETARY INTAKE, ALTERATION In GUT NUTRIENT ABSORPTION, ALTERATION In PROTEIN METABOLISM
Osteoporosis
PROGNOSIS :
In The U.S - Chronic Liver Disease - 10th MOST COMMON CAUSE OF DEATH In Adults
40 % - Due To Alcoholic Cirrhosis
CHILD-PUGH Classification
মেডিকেল বই এর সমস্ত সংগ্রহ -
এখানে দেখুনMedical Guideline Books